H1 secures $40M from CVS, proving SaaS startups can still attract investment
Quick Take
H1 has successfully secured $40 million in funding from CVS, demonstrating that SaaS startups can still attract significant investment. CEO Ariel Katz emphasizes that while AI can replicate workflow SaaS, it cannot duplicate H1's unique doctor data, setting the company apart in the competitive landscape.
Key Points
- H1 raised $40 million from CVS for its unique doctor data platform.
- CEO Ariel Katz highlights the limitations of AI in replicating H1's offerings.
- The funding showcases ongoing investor interest in innovative SaaS solutions.
- H1 differentiates itself in the market with proprietary data assets.
Article Excerpt
From source RSS / original summaryCEO Ariel Katz argues that while AI can replicate workflow SaaS, it can't copy H1’s unique doctor data.
Reader Mode unavailable (could not extract clean content).
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from TechCrunch
See more →
After Nvidia’s $20B not-acqui-hire, AI chip startup Groq reportedly raising $650M
AI chip startup Groq is reportedly raising $650 million to shift its focus from hardware to AI inference, enhancing how AI models respond to prompts. This move follows Nvidia's recent $20 billion not-acqui-hire, indicating a competitive landscape in AI chip development.
